Amgen Inc (AMGN) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NASDAQ

Key Metrics

• Price: $379.33
• Market Cap: $207.18B
• P/E Ratio: 27.03
• EPS: $14.22
• Dividend Yield: 0.02%
• 52-Week High: $387.49
• 52-Week Low: $253.48

Market Sentiment

Amgen Inc currently has a Bullish sentiment score of 0.25.

About Amgen Inc

Amgen Inc. is a prominent multinational biopharmaceutical company headquartered in Thousand Oaks, California, renowned for its innovative therapies rooted in recombinant DNA technology. Specializing in oncology, nephrology, and inflammation, Amgen leverages its expertise in molecular biology to develop and commercialize biologic products that enhance patient outcomes. With a robust drug pipeline and a strong competitive position in the biotechnology sector, Amgen remains at the forefront of m...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Amgen Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

What is AMGN's current dividend yield?

Amgen Inc (AMGN) has a current dividend yield of 0.02%.

Does AMGN pay dividends?

Yes, Amgen Inc pays dividends with a current yield of 0.02%.

What is AMGN's P/E ratio?

Amgen Inc has a price-to-earnings (P/E) ratio of 27.03.

What is AMGN's market cap?

Amgen Inc (AMGN) has a market capitalization of $207.18B with a current stock price of $379.33.